NCT06994325Completed
Testing the CHAT Program for Patients With Heart Failure
A Pilot Hybrid Effectiveness-Implementation Trial for the Conversations Helpful for Awareness of Illness Trajectory (CHAT) Intervention
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
The researchers are studying whether an intervention that involves video-based educational content and a health coach is acceptable, feasible, and effective for people with Heart Failure with Preserved Ejection Fraction (HFpEF).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 20 May 2025
- Start date
- 31 Jul 2025
- Primary completion date
- 28 Aug 2026
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Heart failure
- NCT number
- NCT06994325
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 31 Jul 2025 to the primary completion date, 28 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously referred to hospice care
- Prior completion of advance directives; forms uploaded to the EMR in the past 3 years
Other illness
- Moderate-severe dementia or psychiatric disorder precluding informed consent.
Who the study is looking for
- Male or Female ≥ 60 years old
- Documentation of HFpEF according to clinical practice guidelines
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medical College Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.